ESCRS - Fighting blindness with eye care in the community ;
ESCRS - Fighting blindness with eye care in the community ;

Fighting blindness with eye care in the community

Current ophthalmology waiting list numbers are extremely concerning

Fighting blindness with eye care in the community
Colin Kerr
Colin Kerr
Published: Monday, November 14, 2016
[caption id="attachment_6534" align="alignnone" width="750"]Dr Paul Kenna, Royal Victoria Eye and Ear Hospital, Kevin Whelan, CEO, Fighting Blindness, Prof Jane Farrar, Trinity College Dublin, and Dr Laura Brady, Research Officer, Fighting Blindness Dr Paul Kenna, Royal Victoria Eye and Ear Hospital, Kevin Whelan, CEO, Fighting Blindness, Prof Jane Farrar, Trinity College Dublin, and Dr Laura Brady, Research Officer, Fighting Blindness[/caption] The Irish patient-led charity, Fighting Blindness, has called on the Irish Government to urgently publish the Review of Primary Care Eye Services which would see greater emphasis on eye care services being delivered in the community for stable chronic conditions. The call was made at the Fighting Blindness RETINA 2016 conference. It is estimated that sight loss currently affects more than 246,000 people in Ireland, and this is projected to rise to 272,000 by 20203. Kevin Whelan, Chief Executive Officer, Fighting Blindness, said that the Review of Primary Care Eye Services offers a potential roadmap to providing a more effective service for all patients and addressing waiting lists: "Current ophthalmology waiting list numbers are extremely concerning. They mean that a sight issue will continue to interfere with a person's quality of life for so much longer than is necessary. More particularly, for people with rare degenerative eye conditions, it means that they are not being monitored regularly and so we are not able to learn more about these complex conditions and how they will affect people long-term," he said. The Fighting Blindness Retina 2016 conference was supported by Novartis.
Tags: retina
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;